{"version":"1.0","provider_name":"Redmond Reporter","provider_url":"https:\/\/www.redmond-reporter.com","author_name":"Hannah Saunders","author_url":"https:\/\/www.redmond-reporter.com\/author\/hannah-saunders\/","title":"Redmond biotech company in Phase 1\/2 of pneumococcal vaccine study","type":"rich","width":600,"height":338,"html":"
Redmond biotech company in Phase 1\/2 of pneumococcal vaccine study<\/a><\/blockquote>